Beijing: Chinese biotechnology company Clover Biopharmaceuticals said that a large trial shows its two-dose Covid-19 vaccine is 79% effective against the fast-spreading Delta variant.
The vaccine candidate is 92% effective against the Gamma variant first identified in Brazil, and 59% against the Mu variant first detected in Colombia, according to joint statement issued by the company and the Coalition for Epidemic Preparedness Innovations, a nonprofit organisation that funded the clinical trial.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!